Schrödinger, Inc. (SDGR) Stock

Schrödinger, Inc. (SDGR) is a Healthcare stock trading at $15.78 (as of 2026-06-18), with a market capitalization of $1.12B and a trailing P/E of -10.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Please provide the company’s SEC 10-K “Business” (Item 1) text so I can produce a 1–2 sentence, ~45-word description based only on that primary source (per requirements).

Valuation — source: SEC EDGAR (first-party)
Price$15.78
Market Cap$1.12B
P/E Ratio-10.9
EV / EBITDA-5.4
Price / Book3.59
Price / Sales4.41
DCF Value (model)$6.12
DCF Upside vs Price-61.2%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$255.87M
Net Margin-40.4%
Return on Equity-33.0%
Current Ratio2.74
Revenue Growth (YoY)-1.6%
EPS Growth (YoY)-1.2%
FCF Growth (YoY)-112.1%
Financial Health — source: SEC EDGAR
Altman Z-Score0.85 (distress)
Valuation vs Sector & Industry
Stock P/E-10.9
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-151.8%
vs Industry-162.9%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Insider Sells (12mo)5
Top Institutional HolderVANGUARD GROUP INC ($115.58M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEORamy Farid
Employees891
CountryUS
IPO Date2020-02-06

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Tyra Biosciences, Inc. (TYRA)
  • Immatics N.V. (IMTX)
  • AnaptysBio, Inc. (ANAB)
  • Amylyx Pharmaceuticals, Inc. (AMLX)
  • Palvella Therapeutics, Inc. (PVLA)
  • Septerna, Inc. (SEPN)
  • Savara Inc. (SVRA)
  • Omeros Corporation (OMER)
SDGR earnings history · SDGR institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.